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The keratin patterns of human epidermal keratinocytes cul-
tured on a 3T3-feeder layer in thelresence of 10-8 M non-
aromatic (all-trans retinoic acid an 13-cis retinoic acid) and 
polyaromatic (arotinoid, arotinoid-sulfone, and free arotin-
oic-acid) retinoids were analyzed by high resolution one- and 
two-dimensional gel electrophoresis and immunoblotting. 
Laser densitometric evaluation of one-dimensional gels al-
lowed to quantitate the changes within the keratin patterns 
and revealed an increase in the expression of keratins K13, 
lOS, and K19 as induced by both non-aromatic and polyaro-
matic retinoids, except for the parent compound arotinoid. 
This would then indicate that such keratinocytes are pursu-
ing a more embryonic type of differentiation. 
In evaluating the data for the hyperproliferation-associated 
Keratins comprise a heterogenous family of acidic (PI . 4.5 - 5.5) and neutral-to-basic (pI 6.5 - 7.5) proteins ranging in apparent molecular weight from 40,000 to 67,000. They represent the major structural compo-nents of the water-insoluble intermediate filament 
system in epithelial tissues [1-6]. 
Keratins are usually expressed as specific pairs of acidic (type I) 
and neutral-to-basic (tyre II) subunits, both of which are essential 
for fil ament formation 17 -12]. For example, K5 and K14 are char-
acteristically produced in the basal layer of stratified squamous 
epithelia [13,14) , whereas, in the course of.stratificati.on and diffe:-
entiation, more complex patterns of keratm expressIOn are mam-
fested : terminally differentiating epidermal cells express Kl and 
KlO [2,5,6], suprabasal corneal cell~ exr.ress K3 andK12 [14,15,16], 
and stratified layers of the upper digestive tract epithelium express 
K4 and K13 [17,18]. .. 
In response to epidermal trauma, such as dunng wound healm.g 
but also in psoriatic lesions, the suprabasal cells down-regulate their 
expression of Kl and KI0 and induce the ex~ression 0~K6 and K~6, 
which are therefore called hyperprohferatlOn-assoclated keratms 
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keratins K6 and K16 we noticed an unexpected result: except 
for all-trans retinoic acid, these two keratins showed opposite 
responses. As compared to control cultures, the amount ofK6 
did generally increase, while K16 was reduced, with arotin-
oid acid being the most effective retinoid. The apparent! . 
uncoupled expression of K6 and K16 appeared also to be 
concentration dependent when 13-cis retinoic acid at con-
centrations of 10-9 , 10-8 , and 10- 7 M was analyzed. 
Considering the overall anti proliferative potency of reti-
noids, we therefore conclude that K16 alone~ rather than the 
pair K6/Kl6. $hau.W he regarded as a. proliferation-related 
keratin and as such may be used as a sensitive marker to 
evaluate keratinocyte proliferation. J Invest Dermatol 
95:450-455,1990 
[19-26] . Although the induction ofK6 and K16 correlates with an 
increase in proliferation of epidermal cells, it has not yet clearly 
shown that this switch is indeed functionally important. 
Vitamin A, and its derivatives, are essential for normal epithelia! 
differentiation [27,28]. There are several reports indicating reo-
noids to influence keratin gene expression in a number of different 
ways. Non-aromatic retinoids, at high concentrations, are able ro 
suppress the expression ofK1 and KI0 in cultured epidermal kerati-
nocytes and to induce expression ofK13 and K19, instead [29- 33). 
Considering the successful therapy of psoriasis and other dermato-
logical disorders by retinoids [34], the molecular pathways by which 
these compounds exert their effects still need to be unraveled. 
In this report, we describe the influence of non-aromatic [all-
trans retinoic acid (all-trans RA), 13-cis retinoic acid (13-cis RA)) 
and polyaromatic retinoids (arotinoid, arotinoid sulfone, free am-
tinoic acid) on keratin expression of cultured human epidermal 
keratinocytes using quantitative laser densitometry of extracted 
keratins separated by high resolution one- and two-dimensional gd 
electrophoresis. We have observed an induction of K13, K15, and 
K19 and a reduced expression of the hyperproliferation-associared 
keratin K16, while, except for all-trans RA, K6 was unaltered or 
slightly increased. We therefore conclude that K16 alone may serve 
as a sensitive indicator of keratinocyte proliferation. 
MATERIALS AND METHODS 
Epidertnal Cell Cultures Human keratinocytes were isolated 
from split skin of the thigh by incubating the specimens in PBS (PH 
7.2) containing 0.25% trypsin for 2 h, followed by mechanical agita-
tion. Keratinocytes were seeded at a density of 1 X 104 cells/cm-
and grown on a 3T3-feeder layer [35,36) in modified Dulbecco 
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modified Eagle's medium supplemented with 10% fetal calf serum, 
10 ng/ml epidermal growth factor, 10-9 M cholera toxin, 0.4 mM 
glutamine, 1001U/ml penicillin, 100,ug/ml streptomycin, and 
0.5,ug/rnl amphotericin B. The medium was changed every third 
day. 
For the investigations, keratinocytes in their first subculture were 
used. On day 2, medium supplemented with non-aromatic (all-
trans RA, 13-cis RA) polyaromatic (arotinoid, -sulfone, -acid) reti-
noids at the concentration of 10-8 M was added and changed every 
other day for 10 d. 0.2% DMSO served as control vehicle. Human 
keratinocytes were also cultured under the above conditions with 
all-trans RA and 13-cis RA at concentrations of 10-9 and 10-7 M. 
Preparation of Keratin-Enriched Protein Fractions The 
3T3 feeder layer was selectively removed from confluent cultures of 
epide?TIal keratinocytes with 0.02% EDTA in PBS (pH, 7.2) as 
descnbed [37]. The remaining keratinocytes, from three parallel 
cultures, were then harvested into a centrifuge tube, homogenized 
by ultrasonic disruption in 20 mM Tris/HCl, pH 7.4, containing 
1. mM phe~yl~ethylsulfonyl fluoride and 5 J.lg/ml each of pepsta-
t l.l1 and antlpal11, and extracted twice with 600 mM KCl, 5 mM 
ethylenedinitrilotetraacetic acid (EDTA), 5 mM ethylene-bis(oxy-
ethylenenitri lo)tetraacetic acid (EGTA), 50 mM Tris/HCl, pH 7.4, 
1% Triton X-IOO, and the protease inhibitors as described above. 
Ea~h extraction step included ultrasonic disintegration and centrifu-
gatIon at 27,000 X g. The resulting pellet, highly enriched in cyto-
skeletal proteins, was solubilized in sample buffer (0.5 M Tris/HCI, 
pH 6.8, 2.1 % SDS, 10% mercaptoethanol, 10% glycerol, and 
bromphenolblue) and heated for 10 min at 90°C. 
Gel Electrophoresis and Densitometry One-dimensional so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) according to Laemmli [38] and two-dimensional analyses by 
non-equilibrium pH gradient electrophoresis (NEpHGE) accord-
ing to O'Farrell et al [39] were performed as described by Mischke 
and Wild [40]. Gels were stained in 0.2% Serva-Blue R. For quanti-
ration of protein bands separated by SDS-PAGE a LKB Ultro-Sqn 
XL laser densitometer connected with an IBM-PC PS 2/50 was 
used. K5 (K5b or K5a + K5b, respectively [17,40]) served as an 
internal reference for equal protein loading and for quantification, 
because keratin K5 apparently is unaffected by retinoids both at the 
protein and the mRNA level [30,32]. Thus, the measured levels of 
the other keratins represent their ratio with respect to K5 . The 
quanti tation was performed with the soft-ware program "GeiScan 
XL" (version 1.64). 
Inununoblot Analysis Proteins from unstained one- and two-
dimensional gels were transferred by semi-dry blotting onto nitro-
cellulose sheets as described by Towbin et al [41 ). Unspecific pro-
tein binding sites were blocked in 0.14 M TBS (10 mM Tris/ HCI, 
pH 7.4, and 140 mM NaCI) supplemented with 0.05% Tween 20 
and 15% horse serum. The filters were incubated overnight with 
antikeratin antibodies, washed twice with 0.14 M TBS/ 0.05% 
Tween, and then incubated with horseradish peroxidase-conju-
gated goat anti-rabbit (BIO-RAD, Miinchen, FRG) as secondary 
antibod y. Monoclonal mouse antikeratin antibodies were bridged 
via rabbit anti-mouse IgGs (Dakopatts, Denmark). After washing 
twice w ith 0.14M TBS/ 0.05% Tween and 3 times with 0.14M 
TBS, the peroxidase reaction was developed using 0.02% 4-chloro-
1-naphthol (freshly prepared as a 0.3% solution in methanol) and 
0.015% hydrogen peroxide in 0.14 M TBS. 
The anti-keratin antibodies used were the commercially available 
monoclonal antibodies Ck 4.62 recognizing K19 and K13, and Ck 
8.12 recognizing K16 and K13 (both from ICN, Eschwege), and 
tbe rabbit polyclonal antisera 8-2/4 and 10-2/2 discriminating the 
acidic (type I) and the neutral-to-basic (type II) keratin subfamilies, 
respectively ([40], Wild G and Mischke D, unpublished). 
RESULTS 
Homogenization and extraction of cultured human keratinocytes 
with high salt/Triton X-100 containing buffer yielded water-
insoluble cytoskeletal residues highly enriched in keratin proteins. 
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Figure 1. Two-dimensional separation by NEpHGE/ SDS-PAGE of 
human keratins from epidermal keratinocytes cultured without additional 
retinoids (control) . (a) Coomassie Blue stained gel, (b) immunoblot, reac-
tion with the monoclonal antibodies Ck 4.62 (K19) and Ck 8.12 (K13, K16), 
(c) immunoblot, reaction with 8-2/4 (predominantly type I keratins), (d) 
diagram of keratins expressed in cultured human epidermal keratinocytes 
(on 3T3 feeder layer). Keratins are numbered according co the catalog of 
keratins [4] considering the polymorphic keratins [40]. Keratin pairs are 
shown with identical symbols. 
One- and two-dimensional gel electrophoretic analyses of such 
preparations (Figs 1 and 3, la/Ie 2) displayed keratin profiles that 
were generally consistent with previous reports [1,4,6,29,30,42-
45], showing submerged cultures of human keratinocytes to express 
K5 (K5a + K5b in Fig 3) , K6, K14, K16, K17 and, often at a low 
level, also K13 , K15, and K19 . 
The presence of K13 alr'eady in control cultures is particularly 
noteworthy, because these keratinocytes were obtained from thigh 
epidermis rather than from foreskin and thus should be devoid of 
any contaminating keratinocytes from the wet surface of the fore-
skin that have been shown to synthesize K13 also in vivo [30]. 
When human epidermal keratinocytes were cultured under the 
influence of non-aromatic (all-trans RA, 13-cis RA) and polyaro-
matic retinoids (arotinoid, -sulfone, and -acid) at a concentration of 
PGK 
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Figure 2. Two-dimensional separation by NEpHGE/ SDS-PAGE ofkera-
tins from human epidermal keratinocytes growing in the presence of arotin-
oid acid (10- 8 M) . (aJ Coomassie Blue stained gel, (bJ immunoblot, reaction 
with the monoclonal antibody Ck 4.62, (e) immunoblot, additional reaction 
with Ck 8.12, (d) immunoblot, additional reaction with 8-2/4. 
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Figure 3. One-dimensional SDS-PAGE of human keratins expressed in 
cultured human epidermal keratinocytes. (a) Coomassie Blue stained gel, 
(b) corresponding immunoblot reacted with a mixture of the rabbit poly-
clonal antisera 8-2/4 and 10-2/2 to detect all keratins. Lane 1, human epi-
dermis; lalle 2, DMSO (control); lalle 3, all-trans RA, 10-7M; lalle 4, all- trans 
RA, 10-8M; latle 5, all-trans RA, 10-9M; lane 6, 13-cis RA, 10-7M; latze 7, 
13-cis RA, 1O-8M; lalle 8, 13-cis RA acid, 10-9M. Opell arrowheads, type I; 
closed arrowheads, type II keratins. 
10-8 M, alterations within the keratin patterns were apparent. In 
order to quantitate these changes, keratin-enriched fractions sepa-
rated by one-dimensional gel electrophoresis a~d identified by i~­
munoblot analysis were evaluated by laser densltometry. To faClh-
tate direct comparisons among the samples, we have used Ks as an 
internal reference, because this keratin has been shown to be appar-
ently unaffected by retinoids both at the protein and the mRNA 
level [30,32J. Thus, the amount of keratin determined by laser dens i-
tometry is given as its ratio with respect to Ks. 
As compared to control cultures, the measurements then revealed 
an appreciable increase in expression ofK13, K15, and K19 (Table 
I). In this respect, all-trans RA and arotinoid acid were the most 
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effective retinoids. Although the increase of K13 brought about b" 
arotinoid acid was unevaluable due to insufficient protein loadingl 
became apparent on two-dimensional gels (Fig 2b, c, compare to Fi~ 
Ib). For the parent compound, arotinoid, no effect was detectable, 
Although the quantitative evaluation of K17 revealed a variabl~ 
response of this keratin, K14 showed opposing effects with respeq 
to the two groups of retinoid tested. Non-aromatic retinoids led to" 
reduction and polyaromatic retinoids to an increase of the amoun 
synthesized for this keratin (Table I), thus indicating an altered, 
expression of K14 with respect to its usually coexpressed type II. 
partner keratin K5. . 
When evaluating the data for the hyperproliferation-associat 
keratins K6 and K16, we observed an nnexpected result: except for-
all-trans RA, the expression of K6 increased, whereas K16 \ 
down-regulated. Again, arotinoid acid was the most effective com, 
pound (Table I). 
In order to investigate this apparently uncoupled expression of 
K6 and K16 more thoroughly, we have compared keratin expres-
sion in human epidermal keratinocytes cultured under the influen~ 
of all-trans RA and 13-cis RA at concentrations of 10-9 , 10-8, and 
10-7 M (Fig 3). At 10-9 M, both retinoids induced K6 and K1 6. ln 
contrast, at the higher concentrations all-trans RA inhibited the 
expression of both K6 and K16, whereas 13-cis RA had no or only a 
slightly increasing effect on the expression ofK6, but, again, led toa 
reduction in K16 expression (Fig 4, Table II). 
In addition, a concentration-dependent increase ofKl3, K 15, and 
K19 expression was found that was more pronounced for all-trans 
RA than for 13-cis RA (Table II) . 
DISCUSSION 
The biochemical, immunqlogic, and laser densitometric analyses of 
the keratin profiles of human cultured keratinocytes confirm th~ 
considerable potency of non-aromatic and polyaromatic retinoids to 
influence the growth and differentiation of keratinocytes as re-
flected in the regulation of keratin expression. 
Induction of K13, K15, and K19 Expression by Retinoids 
Although K13, K15, and K19 are usually expressed separately in 
many adult epithelia, their combined expression occurs in embry-
onic development of epidermis. For example, K13 is transiently 
expressed in the two- and three-layered epidermis of fetuses [46,47]· 
in the adult, however, K13 expression apparently is limited to the 
suprabasal cell layers of non-keratinizing squamous epitheha 
[4,14,17,18,48J . K19 is also expressed during embryonic develop-
ment of human epidermis [46,47J, as it is in the course of malignant 
transformation [49J, and in many simple epithelia [4,43,50]. K15, 
together with K4, is also among the earliest markers in developin 
fetal epidermis indicating the beginning of stratification [46]. Al-
though K4 disappears during maturation, expression ofK15 persists 
at a low level and K15-mRNA can be detected in all layers of the 
adult epidermis [51]. Hence, both groups of retinoids are able to 
induce an embryonic phenotype of keratinocyte differentiation. 
Interference ofRetinoids with K6/K16 Expression and Prol. 
iferation Several studies have described the abnormal expression 
of K6 and K16 in diseases of the epidermis [19 - 26,52] conc/udin" 
Table I. Effect of Non-aromatic and Polyaromatic Retinoids (10-8 M) on Keratin Expression' 
K6 K16 K13 K15 K19 K14 K17 
All-trans RA 9 3 + 10 + 31 +79 - 18 + 6 
13-cis RA + 6 2 + 5 +20 + 4 -29 - 11 
Arotinoid + 7 3 n.d.b n.d. n.d. + 1 - 20 
Arotinoid sulfone + 11 2 n.d. + 18 +20 +21 + 39 
Arotinoid acid + 31 -34 n.d. +33 +60 +28 + 12 
.. Laser densitometric evaluation of keratins synthesized in cultures of human epidermal keratinocytcs in the presence of 10-8 M rcrinoids. Values indicate changes (absorption unitS 
• mm) as compared to DMSO (control) cultures. 
I n.d., = not detectable. 
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Figure 4. Densitometric integration curves of one-dimensional immuno-
blots reacted with a mixture of the rabbit polyclonal antisera 8-2/4 and 
10-2/2. (a) DMSO (control); (b) 13-cis RA, 10-7M; (c) all-trans RA, 
1O-9M; (d) all-trans RA, 10-7M (compare Fig 3, /alles 2,6,5, and 3, respec-
tively). Keratins are numbered as described in Fig 1. 
that K6/K16 expression seems to be associated with an increase in 
epidermal proliferation. Therefore, it has been suggested that this 
pair of keratins be used as biochemical markers for hyperproliferat-
ing keratinocytes [15,24). 
In the present study we have evaluated the expression of K6 and 
K1 6 in cultured human keratinocytes fo llowing treatment with a 
set of different retinoids. In agreement with other reports [53,54), 
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all-trans RA did inhibit the expression of both K6 and K16 in a 
concentration-dependent manner. For all other retinoids tested, 
however, the paired expression ofK6 and K16 became uncoupled, 
with arotinoid acid being the most effective compound. The 
marked inhibition ofK16 expression correlates well with the results 
measuring 3H-thymidine incorporation into DNA by autoradiogra-
phy, when keratinocytes are cultured in the presence of polyaroma-
tic retinoids [55). Therefore, a close correlation between prolifera-
tion and expression ofK16 in normal cultured keratinocytes must 
exist . 
However, a recent report [53) emphasizes that expression ofK6/ 
K16 and epidermal hyperproliferation may not always be linked, 
because a marked inhibition ofK6/K16 expression, but no decline 
in cell proliferation, was observed in the human squamous cell carci-
noma line SCC-13, when cells were culrured on floating rafts at the 
air-liquid interface and exposed to retinoic acid. 
The reason for the different findings in normal epidermal kerati-
nocytes and in SCC-13 cells may be related to. the specific retinoid 
used, because we also detected a weak suppression of proliferation 
and K6/K16 expression by all-trans RA, whereas arotinoid acid, 
generally accepted to have a higher antiproliferative capacity, re-
vealed the marked inhibition of just K16. Finally, it should be CQn-
sidered that SCC-13 is a tumor cell line derived from a facial epider-
mal tumor that had received series of radiation treatments before 
surgical removal [56). Hence, we would be rather cautious to com-
pare normal and neoplastic proliferation behavior, the more as it is 
not completely understood how neoplastic growth is initiated and 
maintained. 
Thus, considering both proliferation and K16 gene expression 
being decreased under the influence of retinoids, K16 apparently is 
the only proliferation-associated keratin. Support for this conclu-
sion may also be drawn from the particular distribution of K16 in 
hyperproliferative epidermis as assessed by monoclonal antibody 
studies [57). 
Knowing about the antiproliferative effects of retinoids on kerati-
nocytes in cell culture and in therapy of psoriasis [34,58,59) we 
therefore suggest that K16 may be used as a .sensitive marker to 
evaluate the anti proliferative potency of retinoids in non-trans-
formed keratinocytes. The qUl!stion, however, whether modulation 
of K6/ K16 expression is a cause or a frequent consequence of the 
hyperproliferative state remains and more experiments will be nec-
essary to further define the molecular pathways by which retinoids 
exert their action on proliferation and on regulation of keratin ex-
pression. 
Reflecting clinical application of all-trans RA and 13-cis RA, the 
observed uncoupled expression of K6/K16 may explain why oral 
application of 13-cis RA is much better tolerated than oral treatment 
with all-trans R:'\, which is im~ossible becaus~ of its side effects. 
Thus it is conceIvable that the linked suppreSSIOn of K6 and K16 
results in a non-tolerable intervention of homoeostasis of the cell 
whereas the uncoupling of K6 and K16 expression just exerts an 
imbalance within the intermediate filament system which, possibly, 
can be better compensated. 
Table II. Concentration-Dependent Changes in Keratin Expressiona 
K6 K16 K13 K15 K19 K14 K17 
All-trans RA, 10- 9 M + 12 + 4 + 2 + 17 + 8 -23 3 
All-trans RA, 10-'-8 M - 9 - 3 + 10 + 31 + 79 -18 + 6 
All-trans RA, 10- 7 M -15 - 8 +40 +67 + 168 - 18 + 4 
13-cis RA, 10-9 M + 17 + 17 + 2 n.d.b 18 0 +21 
13-cis RA, 10-8 M + 6 - 2 + 5 +20 + 4 -29 -11 
13-cis RA, 10- 7 M 0 - 11 + 15 +32 + 83 -17 -18 
• Quantification of changes in keratin expression in human epidermal keratinocytes cultured in the presence of different concentrations of al·trans RA and 13-cis RA as compared to 
DMSO (control) cultures . 
• n.d., = not detectable. 
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Our ~esults thus merit add~tiona l in vitro and in vivo experiments 
to obtam further I11s1ghts mto the action of non-aromatic and 
polyaromatic retinoids. 
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